Xiao Wang1, Avanthi Raghavan1, Derek T Peters1, Evanthia E Pashos1, Daniel J Rader1, Kiran Musunuru2. 1. From the Cardiovascular Institute (X.W., E.E.P., D.J.R., K.M.), Department of Medicine (X.W., E.E.P., D.J.R., K.M.), and Department of Genetics (X.W., E.E.P., D.J.R., K.M.), Perelman School of Medicine, University of Pennsylvania, Philadelphia; and Harvard Medical School, Boston, MA (A.R., D.T.P.). 2. From the Cardiovascular Institute (X.W., E.E.P., D.J.R., K.M.), Department of Medicine (X.W., E.E.P., D.J.R., K.M.), and Department of Genetics (X.W., E.E.P., D.J.R., K.M.), Perelman School of Medicine, University of Pennsylvania, Philadelphia; and Harvard Medical School, Boston, MA (A.R., D.T.P.). kiranmusunuru@gmail.com.
Abstract
OBJECTIVE: The noncoding single-nucleotide polymorphism rs12740374 has been hypothesized to be the causal variant responsible for liver-specific modulation of SORT1(sortilin 1) expression (ie, expression quantitative trait locus) and, by extension, the association of the SORT1 locus on human chromosome 1p13 with low-density lipoprotein cholesterol levels and coronary heart disease. The goals of this study were to compare 3 different hepatocyte models in demonstrating that the rs12740374 minor allele sequence is responsible for transcriptional activation of SORT1 expression. APPROACH AND RESULTS: We found that although primary human hepatocytes of varied rs12740374 genotypes strongly replicated the SORT1 expression quantitative trait locus observed previously in whole-liver samples, a population cohort of induced pluripotent stem cell-derived hepatocyte-like cells poorly replicated the expression quantitative trait locus. In primary human hepatocytes from multiple individuals heterozygous at rs12740374, we used CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats-associated 9) to specifically target the rs12740374 minor allele sequence ex vivo, resulting in a reproducible reduction in SORT1 expression. We generated a locus-humanized transgenic mouse with a bacterial artificial chromosome bearing the human SORT1 locus with the rs12740374 minor allele. In this mouse model, we used CRISPR-Cas9 to target the rs12740374 minor allele sequence in the liver in vivo, resulting in a substantial reduction of hepatic SORT1 expression. CONCLUSIONS: The rs12740374 minor allele sequence enhances SORT1 expression in hepatocytes. CRISPR-Cas9 can be used in primary human hepatocytes ex vivo and locus-humanized mice in vivo to interrogate the function of noncoding regulatory regions. Induced pluripotent stem cell-derived hepatocyte-like cells experience limitations that prevent faithful modelling of some hepatocyte expression quantitative trait loci.
OBJECTIVE: The noncoding single-nucleotide polymorphism rs12740374 has been hypothesized to be the causal variant responsible for liver-specific modulation of SORT1(sortilin 1) expression (ie, expression quantitative trait locus) and, by extension, the association of the SORT1 locus on human chromosome 1p13 with low-density lipoprotein cholesterol levels and coronary heart disease. The goals of this study were to compare 3 different hepatocyte models in demonstrating that the rs12740374 minor allele sequence is responsible for transcriptional activation of SORT1 expression. APPROACH AND RESULTS: We found that although primary human hepatocytes of varied rs12740374 genotypes strongly replicated the SORT1 expression quantitative trait locus observed previously in whole-liver samples, a population cohort of induced pluripotent stem cell-derived hepatocyte-like cells poorly replicated the expression quantitative trait locus. In primary human hepatocytes from multiple individuals heterozygous at rs12740374, we used CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats-associated 9) to specifically target the rs12740374 minor allele sequence ex vivo, resulting in a reproducible reduction in SORT1 expression. We generated a locus-humanized transgenicmouse with a bacterial artificial chromosome bearing the humanSORT1 locus with the rs12740374 minor allele. In this mouse model, we used CRISPR-Cas9 to target the rs12740374 minor allele sequence in the liver in vivo, resulting in a substantial reduction of hepatic SORT1 expression. CONCLUSIONS: The rs12740374 minor allele sequence enhances SORT1 expression in hepatocytes. CRISPR-Cas9 can be used in primary human hepatocytes ex vivo and locus-humanized mice in vivo to interrogate the function of noncoding regulatory regions. Induced pluripotent stem cell-derived hepatocyte-like cells experience limitations that prevent faithful modelling of some hepatocyte expression quantitative trait loci.
Authors: Mads Kjolby; Olav M Andersen; Tilman Breiderhoff; Anja W Fjorback; Karen Marie Pedersen; Peder Madsen; Pernille Jansen; Joerg Heeren; Thomas E Willnow; Anders Nykjaer Journal: Cell Metab Date: 2010-09-08 Impact factor: 27.287
Authors: Qiurong Ding; Alanna Strong; Kevin M Patel; Sze-Ling Ng; Bridget S Gosis; Stephanie N Regan; Chad A Cowan; Daniel J Rader; Kiran Musunuru Journal: Circ Res Date: 2014-06-10 Impact factor: 17.367
Authors: Shiaoching Gong; Chen Zheng; Martin L Doughty; Kasia Losos; Nicholas Didkovsky; Uta B Schambra; Norma J Nowak; Alexandra Joyner; Gabrielle Leblanc; Mary E Hatten; Nathaniel Heintz Journal: Nature Date: 2003-10-30 Impact factor: 49.962
Authors: Eric E Schadt; Cliona Molony; Eugene Chudin; Ke Hao; Xia Yang; Pek Y Lum; Andrew Kasarskis; Bin Zhang; Susanna Wang; Christine Suver; Jun Zhu; Joshua Millstein; Solveig Sieberts; John Lamb; Debraj GuhaThakurta; Jonathan Derry; John D Storey; Iliana Avila-Campillo; Mark J Kruger; Jason M Johnson; Carol A Rohl; Atila van Nas; Margarete Mehrabian; Thomas A Drake; Aldons J Lusis; Ryan C Smith; F Peter Guengerich; Stephen C Strom; Erin Schuetz; Thomas H Rushmore; Roger Ulrich Journal: PLoS Biol Date: 2008-05-06 Impact factor: 8.029
Authors: Yang Yang; Lili Wang; Peter Bell; Deirdre McMenamin; Zhenning He; John White; Hongwei Yu; Chenyu Xu; Hiroki Morizono; Kiran Musunuru; Mark L Batshaw; James M Wilson Journal: Nat Biotechnol Date: 2016-02-01 Impact factor: 54.908
Authors: Alan Kwong; Andrew P Boughton; Mukai Wang; Peter VandeHaar; Michael Boehnke; Gonçalo Abecasis; Hyun Min Kang Journal: Bioinformatics Date: 2021-08-30 Impact factor: 6.931
Authors: Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty Journal: Arterioscler Thromb Vasc Biol Date: 2019-12-23 Impact factor: 8.311
Authors: Charles P Fulco; Joseph Nasser; Thouis R Jones; Glen Munson; Drew T Bergman; Vidya Subramanian; Sharon R Grossman; Rockwell Anyoha; Benjamin R Doughty; Tejal A Patwardhan; Tung H Nguyen; Michael Kane; Elizabeth M Perez; Neva C Durand; Caleb A Lareau; Elena K Stamenova; Erez Lieberman Aiden; Eric S Lander; Jesse M Engreitz Journal: Nat Genet Date: 2019-11-29 Impact factor: 38.330
Authors: Pan Gao; Qing Lyu; Amr R Ghanam; Cicera R Lazzarotto; Gregory A Newby; Wei Zhang; Mihyun Choi; Orazio J Slivano; Kevin Holden; John A Walker; Anastasia P Kadina; Rob J Munroe; Christian M Abratte; John C Schimenti; David R Liu; Shengdar Q Tsai; Xiaochun Long; Joseph M Miano Journal: Genome Biol Date: 2021-03-16 Impact factor: 13.583